ERBB2 and breast cancer: constructed three models for predicting molecular subtypes of breast cancer based on digital breast tomosynthesis (DBT), and they suggested that the radiomics features were superior for predicting TNBC over HER2 and luminal-like subtypes (AUC: 0.838, 0.556, and 0.645) (35).